Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Wet Age-related Macular Degeneration”

Showing 20 of 0 results

Not applicableEnded earlyNCT02005133
What this trial is testing

A Prospective, Observational, Multicentre, 2 Year Study Evaluating the Use of Eylea (Aflibercept) for the Treatment of Neovascular (Wet) Age-related Macular Degeneration in UK NHS Opthalmology Clinics

Who this might be right for
Wet Age-related Macular Degeneration
Novartis Pharmaceuticals 188
Testing effectiveness (Phase 2)Active Not RecruitingNCT05230537
What this trial is testing

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Novartis Pharmaceuticals 168
Early research (Phase 1)Not Yet RecruitingNCT07764965
What this trial is testing

Evaluation of PAN-90806 Eye Drops in Healthy Subjects

Who this might be right for
Wet Age Related Macular DegenerationNeovascular (Wet) Age-Related Macular Degeneration
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. 20
Large-scale testing (Phase 3)Study completedNCT04264819
What this trial is testing

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 295
Testing effectiveness (Phase 2)Enrolling By InvitationNCT03999801
What this trial is testing

Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy

Who this might be right for
Neovascular Age-related Macular DegenerationWet Macular Degeneration
AbbVie 865
Testing effectiveness (Phase 2)Active Not RecruitingNCT05387837
What this trial is testing

Safety, Tolerability and PK of Subcutaneous D-4517.2 in Subjects With Wet AMD or DME

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Ashvattha Therapeutics, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT00320788
What this trial is testing

Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Regeneron Pharmaceuticals 159
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06839339
What this trial is testing

Efficacy and Safety of AL-001 Ophthalmic Injection in Subjects with WAMD

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)
Beijing Anlong Biopharmaceutical Co., Ltd. 40
Not applicableLooking for participantsNCT06859515
What this trial is testing

A Long-term Follow up Study of EXG102-031 in Participants With wAMD

Who this might be right for
Wet Age-related Macular Degeneration
Guangzhou Jiayin Biotech Ltd 42
Early research (Phase 1)Study completedNCT00725686
What this trial is testing

Study of PF-04523655 (REDD14NP) In Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (Wet AMD)

Who this might be right for
Age-Related Macular Degeneration
Quark Pharmaceuticals 54
Not applicableWithdrawnNCT01339949
What this trial is testing

Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)

Who this might be right for
Wet Age-related Macular DegenerationAge-related Macular DegenerationAMD+2 more
Oraya Therapeutics, Inc.
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05210803
What this trial is testing

Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
AbbVie 116
Testing effectiveness (Phase 2)Study completedNCT01535950
What this trial is testing

Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age-elated Macular Degeneration (Wet AMD)Exudative Macular Degeneration
Novartis Pharmaceuticals 43
Testing effectiveness (Phase 2)Looking for participantsNCT05197270
What this trial is testing

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
4D Molecular Therapeutics 215
Not applicableStudy completedNCT02055612
What this trial is testing

Mobile Clinic - a Cross-sectional Epidemiological Survey

Who this might be right for
Age Related Macular Degeneration
Novartis Slovakia, s.r.o. 3,278
Not applicableStudy completedNCT01404845
What this trial is testing

Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine Supplementation

Who this might be right for
Exudative Age-related Macular Degeneration
Affordance 200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07816315
What this trial is testing

Phase 3 Study of Intravitreal OLN324 in Adults With Neovascular (Wet) Age-related Macular Degeneration (nAMD) (OLN324-CP-04)

Who this might be right for
Wet Age Related Macular Degeneration
Ollin Biosciences, Inc. 500
Large-scale testing (Phase 3)Study completedNCT03823287
What this trial is testing

Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

Who this might be right for
Wet Macular Degeneration
Hoffmann-La Roche 671
Testing effectiveness (Phase 2)Ended earlyNCT00094120
What this trial is testing

MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Genaera Corporation 60
Testing effectiveness (Phase 2)Looking for participantsNCT07185841
What this trial is testing

Safety and Efficacy of Oral HX9428 Tablets in Subjects With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration (AMD)
Fujian Haixi Pharmaceuticals Co., Ltd. 198
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation